This bill requires the Louisiana Department of Health to set minimum reimbursement rates for nonemergency medical transportation services used by Medicaid recipients. It establishes a minimum payment of $14.50 per trip plus $2.10 per mile for transportation providers. The Louisiana Department of Health must implement these changes by October 1, 2026, through a Medicaid state plan amendment. This policy change directly affects transportation providers serving Medicaid patients and the state's healthcare administration.
This bill requires nursing homes in Louisiana to have a permanently installed generator or alternative power source on-site to ensure electricity during emergencies. Facilities must store fuel or other power generation materials either on-site or ensure they are delivered before any emergency occurs. The law updates existing regulations to mandate these backup power capabilities for nursing facilities. This change directly affects nursing home operators who must now maintain specific power infrastructure and fuel supplies. The legislation focuses on improving emergency preparedness without specifying particular outcomes or advocating for a particular viewpoint.
HB 732 allows Louisiana's Motor Vehicle Office to temporarily waive outstanding fees, fines, or license suspensions for up to 30 days when a person needs immediate access to life-sustaining medical treatment due to a life-threatening condition. It directly affects individuals with delinquent debt to the Motor Vehicle Office who provide documentation from a licensed physician or medical provider verifying the emergency. The bill requires the office to issue a written decision for each waiver and specifies that the temporary suspension does not forgive the underlying debt, though the commissioner may still reduce or eliminate the obligation at their discretion. This change takes effect upon gubernatorial approval or legislative override of a veto.
This bill updates the rules for licensing occupational therapists and occupational therapy assistants in Louisiana. It requires applicants to pass a national certification exam administered by the National Board for Certification in Occupational Therapy and establishes specific fees for applying for and renewing licenses. The legislation also creates several pathways to waive the exam requirement, including for those already certified before the law takes effect, those licensed in other states with equivalent standards, state employees in specific therapy roles, and graduates of member nations of the World Federation of Occupational Therapists. Additionally, it exempts therapists working in state facilities or agencies from continuing education requirements and clarifies the professional titles and abbreviations that licensed individuals may use.
HB 1249 amends the rules governing school-based health centers to ensure their operations align with specific existing provisions within the same legislative section. This change directly affects the administration of health services provided to students by requiring consistency between different parts of the governing text. The bill does not introduce new services or funding but rather clarifies how current regulations should be interpreted and applied. By adding a reference clause, the legislation streamlines the legal framework for these health programs without altering their core functions.
SB 43 establishes Louisiana's Psychedelic-Assisted Therapy Program within the Department of Health to fund clinical studies using psychedelic medications (like psilocybin) for treating opioid use disorders, co-occurring substance use disorders, and treatment-resistant mental health conditions. The program requires academic health centers to meet strict federal and state compliance standards - including FDA approval, safety protocols, and therapist qualifications - to conduct these studies. Eligible patients, including those with the specified conditions, may participate, and parishes can use opioid settlement funds to enroll residents. The bill mandates annual progress reports from participating centers and requires coordination with other states conducting similar research. This is a research-focused program, not a policy allowing general therapeutic use.
HB 352 requires Louisiana public school districts to create and publish policies enabling behavioral health services for students during school hours. It allows services in classrooms during instructional time (including core subjects) if parents provide a provider-approved evaluation and treatment plan showing medical necessity, with in-person supervision by certified behavior analysts required. The bill defines key terms like "medically necessary services" and mandates that schools collaborate with providers to schedule services without disrupting school operations or testing. It directly affects public school students needing behavioral health support, their parents, school administrators, and behavioral health providers.
HB 1236 amends Louisiana laws governing pharmacy benefit manager reimbursements to establish a new payment formula based on claims data. This formula requires that reimbursement adjustments aim for a claim payment error rate of no more than two percent per drug. The bill also mandates that professional dispensing fees paid to pharmacists must be at least equal to the fee currently set by the Louisiana Department of Health for Medicaid. These changes directly affect pharmacy benefit managers and the state's Medicaid program by updating how they are compensated for dispensing medications.
SB 401 establishes a Prescription Drug Affordability Board within Louisiana's Department of Insurance to address rising prescription drug costs. The board would require drug manufacturers to report detailed pricing data - including production costs, research expenses, and marketing costs - and develop a list of "critical" drugs based on factors like public healthcare costs, usage, and availability of similar treatments. For drugs on this list, the board would set maximum allowable prices for sale in Louisiana, directly affecting manufacturers, pharmacies, and residents who purchase these medications. The bill aims to increase price transparency and control costs through data-driven price-setting, but it has not yet been enacted as it remains prefiling status.
SB 387 amends Louisiana law to regulate pharmacy benefit managers (PBMs), directly affecting PBMs, local pharmacies, health insurers, and patients. It establishes new definitions (like "Maximum Allowable Cost List" and "Effective rate pricing"), requires PBMs to provide transparent compensation and services to enrollees and providers, and creates a private right to sue for violations. The bill also mandates audits of PBM practices, sets penalties for noncompliance, and repeals outdated provisions. These changes aim to increase transparency and accountability in how PBMs handle prescription drug pricing and reimbursements within Louisiana.
